1. Home
  2. QURE vs PAHC Comparison

QURE vs PAHC Comparison

Compare QURE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$25.30

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$39.59

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QURE
PAHC
Founded
1998
1946
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
QURE
PAHC
Price
$25.30
$39.59
Analyst Decision
Strong Buy
Hold
Analyst Count
12
4
Target Price
$58.55
$31.25
AVG Volume (30 Days)
1.7M
204.5K
Earning Date
02-26-2026
02-05-2026
Dividend Yield
N/A
1.23%
EPS Growth
N/A
288.74
EPS
N/A
1.67
Revenue
$15,751,000.00
$1,399,676,000.00
Revenue This Year
N/A
$15.34
Revenue Next Year
$142.93
$3.28
P/E Ratio
N/A
$23.35
Revenue Growth
N/A
33.72
52 Week Low
$7.76
$16.16
52 Week High
$71.50
$46.42

Technical Indicators

Market Signals
Indicator
QURE
PAHC
Relative Strength Index (RSI) 55.22 48.31
Support Level $21.64 $38.29
Resistance Level $25.80 $42.82
Average True Range (ATR) 1.74 1.56
MACD 0.47 0.11
Stochastic Oscillator 53.94 34.52

Price Performance

Historical Comparison
QURE
PAHC

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: